Background <p>Major depressive disorder (MDD) and bipolar disorder (BD) commonly emerge during adolescence, a critical stage of brain development. Characterizing their shared and distinct neurobiological features is essential for early differential diagnosis.</p> Methods <p>In this study, we investigated adolescents with major depressive disorder (MDD) (<i>n</i> = 48), bipolar disorder (BD) (<i>n</i> = 37), and healthy controls(<i>n</i> = 40). We acquired diffusion tensor imaging (DTI) data and applied a combined framework of graph-theoretical analysis and fixel-based analysis (FBA). We reconstructed structural networks using deterministic tractography and calculated global and nodal graph metrics. We then used FBA to measure fiber density (FD), fiber cross-section (FC), and combined FDC across major white matter tracts. We tested group differences and examined correlations with clinical severity after multiple-comparison correction.</p> Results <p>Global graph metrics did not differ across groups, whereas nodal alterations were observed in regions assigned to the default mode, salience, and central executive networks, with disorder specific patterns. Fixel based analysis indicated widespread tract involvement in major depressive disorder but more circumscribed abnormalities in bipolar disorder, particularly in the corpus callosum and fornix. Several metrics were associated with symptom severity.</p> Conclusions <p>These findings suggest disorder-related alterations in nodal topological properties and fiber-specific microstructure in adolescent MDD and BD, providing insight into the neurobiological basis of mood symptoms during this developmental stage. While these structural features may assist future efforts in differential characterization or individualized risk assessment, their potential clinical utility requires further validation.</p> Clinical trial number <p>Not applicable.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Structural network alterations in adolescent major depression and bipolar disorder: a graph-theoretical and fixel-based analysis

  • Yijia Zhou,
  • Yuhang Yang,
  • Zixuan Cheng,
  • Jingwen Liu,
  • Yu Zhang,
  • Jiaxin Luo,
  • Xingyin Huang,
  • Mingke Liu,
  • Can Liu,
  • Du Lei,
  • Liangbo Hu

摘要

Background

Major depressive disorder (MDD) and bipolar disorder (BD) commonly emerge during adolescence, a critical stage of brain development. Characterizing their shared and distinct neurobiological features is essential for early differential diagnosis.

Methods

In this study, we investigated adolescents with major depressive disorder (MDD) (n = 48), bipolar disorder (BD) (n = 37), and healthy controls(n = 40). We acquired diffusion tensor imaging (DTI) data and applied a combined framework of graph-theoretical analysis and fixel-based analysis (FBA). We reconstructed structural networks using deterministic tractography and calculated global and nodal graph metrics. We then used FBA to measure fiber density (FD), fiber cross-section (FC), and combined FDC across major white matter tracts. We tested group differences and examined correlations with clinical severity after multiple-comparison correction.

Results

Global graph metrics did not differ across groups, whereas nodal alterations were observed in regions assigned to the default mode, salience, and central executive networks, with disorder specific patterns. Fixel based analysis indicated widespread tract involvement in major depressive disorder but more circumscribed abnormalities in bipolar disorder, particularly in the corpus callosum and fornix. Several metrics were associated with symptom severity.

Conclusions

These findings suggest disorder-related alterations in nodal topological properties and fiber-specific microstructure in adolescent MDD and BD, providing insight into the neurobiological basis of mood symptoms during this developmental stage. While these structural features may assist future efforts in differential characterization or individualized risk assessment, their potential clinical utility requires further validation.

Clinical trial number

Not applicable.